Related references
Note: Only part of the references are listed.Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal
George W. Burke et al.
PEDIATRIC NEPHROLOGY (2023)
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
Aleksandra Zurowska et al.
PEDIATRIC NEPHROLOGY (2023)
Successful global anti-B-cell strategy with daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab
Jean-Daniel Delbet et al.
PEDIATRIC TRANSPLANTATION (2023)
Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus
Tobias Alexander et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects
Aditi Sinha et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)
Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation
Hefsa Rashed Al Shams et al.
TRANSPLANTATION REVIEWS (2022)
New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
Biswanath Basu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra
Andrea Angeletti et al.
KIDNEY INTERNATIONAL REPORTS (2022)
UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant
Ben C. Reynolds et al.
PEDIATRIC NEPHROLOGY (2022)
Anti-rituximab antibodies in pediatric steroid-dependent nephrotic syndrome
Quentin Bertrand et al.
PEDIATRIC NEPHROLOGY (2022)
A case of treatment-resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumab
Stefanie W. Benoit et al.
PEDIATRIC TRANSPLANTATION (2022)
Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
Andrea Angeletti et al.
KIDNEY INTERNATIONAL REPORTS (2022)
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study
Camille Lanaret et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2021)
Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
Marie Burns et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Rituximab vs Low-Dose Mycophenolate Mofetil In Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults A Randomized Clinical Trial
Pietro Ravani et al.
JAMA PEDIATRICS (2021)
Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol
Francesca Lugani et al.
BMJ OPEN (2021)
A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome
Claire Dossier et al.
PEDIATRIC NEPHROLOGY (2021)
Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis
Manuela Colucci et al.
PEDIATRIC NEPHROLOGY (2020)
Recurrence of FSGS after Kidney Transplantation in Adults
Audrey Uffing et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial
Pietro Ravani et al.
PEDIATRIC NEPHROLOGY (2020)
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
Sonia Boyer-Suavet et al.
FRONTIERS IN IMMUNOLOGY (2020)
Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation
Josselin Bernard et al.
PEDIATRIC NEPHROLOGY (2020)
Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis
Andrea Angeletti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
Lennard Ostendorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Binding mechanisms of therapeutic antibodies to human CD20
Anand Kumar et al.
SCIENCE (2020)
Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis
Ozkan Varan et al.
MODERN RHEUMATOLOGY (2019)
Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report
D. Argiolas et al.
TRANSPLANTATION PROCEEDINGS (2019)
Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child
Sonia Solomon et al.
PEDIATRIC TRANSPLANTATION (2019)
Successful management of recurrent focal segmental glomerulosclerosis
Katrin Kienzl-Wagner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Idiopathic nephrotic syndrome in children
Damien G. Noone et al.
LANCET (2018)
Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome
Josselin Bernard et al.
PEDIATRIC TRANSPLANTATION (2018)
A large, international study on post-transplant glomerular diseases: the TANGO project
Audrey Uffing et al.
BMC NEPHROLOGY (2018)
Management of steroid-resistant nephrotic syndrome in children and adolescents
Kjell Tullus et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Rituximab for nephrotic syndrome in children
Kazumoto Iijima et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)
Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab
Marina Vivarelli et al.
PEDIATRIC NEPHROLOGY (2017)
CD55 Deficiency and Protein-Losing Enteropathy
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ofatumumab for the treatment of childhood nephrotic syndrome
Chia-Shi Wang et al.
PEDIATRIC NEPHROLOGY (2017)
Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes
Cyril Garrouste et al.
TRANSPLANTATION (2017)
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study
Dario Roccatello et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
New biologics in the treatment of rare glomerular diseases of childhood
Paolo Cravedi et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline
A. Prica et al.
CLINICAL ONCOLOGY (2017)
CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease
Roberto Bassi et al.
DIABETOLOGIA (2016)
B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS
Marianne Delville et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis
Anna Francis et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Primary glomerulonephritides
Juergen Floege et al.
LANCET (2016)
Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry
Maria Pippias et al.
TRANSPLANTATION (2016)
Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report
A. Kolonko et al.
TRANSPLANTATION PROCEEDINGS (2016)
Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis
Eduardo H. Garin et al.
PEDIATRIC NEPHROLOGY (2015)
Role of Podocyte B7-1 in Diabetic Nephropathy
Paolo Fiorina et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Ofatumumab for Rituximab- Resistant Nephrotic Syndrome
Biswanath Basu
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient
Jang-Hee Cho et al.
RENAL FAILURE (2014)
Abatacept in B7-1-Positive Proteinuric Kidney Disease
Chih-Chuan Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO
Rebecca M. Lombel et al.
PEDIATRIC NEPHROLOGY (2013)
Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome
Anne-Laure Sellier-Leclerc et al.
PEDIATRIC NEPHROLOGY (2013)
Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
Alberto Magnasco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life
Debbie S. Gipson et al.
KIDNEY INTERNATIONAL (2011)
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis
Alessia Fornoni et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
Melanie S. Joy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome: Multicentric Report
Ashima Gulati et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
Kenneth R. Carson et al.
LANCET ONCOLOGY (2009)
Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T cells
Syamal K. Datta
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2009)
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
D. Albert et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome
Viktoria Sumegi et al.
PEDIATRIC NEPHROLOGY (2008)
Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis
J. M. Yabu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Rituximab in patients with the steroid-resistant nephrotic syndrome
Arvind Bagga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment
MD Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
B7-1 and B7-2: Similar costimulatory ligands with different biochemical, oligomeric and signaling properties
S Bhatia et al.
IMMUNOLOGY LETTERS (2006)
Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome
K Nozu et al.
PEDIATRIC NEPHROLOGY (2005)
Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy
K Benz et al.
PEDIATRIC NEPHROLOGY (2004)
Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trials
AM Durkan et al.
KIDNEY INTERNATIONAL (2001)
Share Paper
